Bayer appeals US$20.5 mln Roundup ruling on cancer case


Bayer, which acquired Roundup with its purchase of Monsanto for US$63 billion in 2018, said the July decision by the California Court of Appeal affirming a 2018 jury verdict in favor of Dewayne Johnson would be relied upon by other courts handling cases over the widely used herbicide. A San Francisco jury initially awarded Johnson $289.2 million after finding the chemical glyphosate in Roundup caused his non-Hodgkin's lymphoma.

Bayer AG has asked California's Supreme Court to review a decision awarding $20.5 million to a groundskeeper who claimed the company's Roundup weedkiller caused his cancer, arguing the ruling was at odds with federal law and settled legal principles.

Bayer, which acquired Roundup with its purchase of Monsanto for US$63 billion in 2018, said the July decision by the California Court of Appeal affirming a 2018 jury verdict in favor of Dewayne Johnson would be relied upon by other courts handling cases over the widely used herbicide.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Bayer , Roundup , cancer , weed-killer , appeal award ,

   

Next In Business News

Industrial projects look increasingly attractive
Protecting trade is protecting yourself
Dutch Lady’s balancing act amid escalating costs
Fed dampens hopes for rate cut
F&N to use cost management measures
Yew Lee expects to return to profitability on wider customer base
Naza makes entry into green economy
CapBay aims to provide financing to more SMEs
Changing office space requirements
New initiative for infrastructure needs in Perak

Others Also Read